A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics.

Br J Clin Pharmacol · 2023 · PMC10087178 · PMID 35942816

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

As the ABCG2 c.34G > A SNV showed only a borderline significant association without correction for multiple testing and has shown an opposite association with rosuvastatin pharmacokinetics in a previous study, 32 it was excluded from further analyses. 3.3.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.